Ms. Ashley Poo was diagnosed with depression five years ago when she was 19 years old. To address her depression symptoms, she was prescribed fluvoxamine, an antidepressant, to take every day.
But even in the beginning, her experience with the drug was anything but joyful. She experienced unpleasant episodes of nausea, appetite loss, and even a rise in suicidal thoughts almost quickly after beginning the medicine.
November marks precisely five years since Ms. Poo started taking her regular dose of antidepressants, and the now 24-year-old project coordinator claimed that these adverse effects persisted for almost a month until they started to go away.
Ms. Poo is among the increasing number of young adults in Singapore who have been prescribed “selective serotonin reuptake inhibitors,” or SSRIs, a kind of antidepressants, in recent years.
Since the late 1980s, SSRIs have been the most widely prescribed class of antidepressants. They function by raising the brain’s concentration of serotonin, a neurotransmitter that aids in mood regulation.
Also Read:
Vietnam’s Quarterly Export and Investment Growth Reaches a Two-year High
PM Wong Congratulates Harini Amarasuriya, his Colleague from Sri Lanka
